The secretion of endothelin-1 by microvascular endothelial cells from human benign prostatic hyperplasia is inhibited by vascular endothelial growth factor

Growth Factors

Volumn 22, Issue 4, 2004, Pages 281-289

  Stachon, Axel ^a   Schlüter, Tanja ^a   Junker, Klaus ^a   Knopf, Hans Jürgen ^b   Neuser, Rolf Dieter ^c   Krieg, Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b District Hospital Dortmund Nord   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

ET 1; Microvascular endothelial cells; Prostate; TNF ; VEGF

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBODY; CD31 ANTIGEN; CELL ANTIGEN; DISPASE; ENDOTHELIN 1; GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

AGED; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL SELECTION; CELL STRUCTURE; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INCUBATION TIME; INHIBITION KINETICS; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; AGED; ANTIGENS, CD31; CELLS, CULTURED; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PROSTATIC HYPERPLASIA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 12344282747     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.1080/08977190400004835     Document Type: Article

References (41)

1. Andersson, K.E., Chapple, C.R. and Hofner, K. (2002) "Future drugs for the treatment of benign prostatic, hyperplasia", World J. Urol. 19, 436-442.
2. Campbell, C.L., Savarese, D.M., Quesenberry, P.J. and Savarese, T.M. (1999) "Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor", Int. J. Cancer 80, 868-874.
3. Carducci, M.A., Padley, R.J., Breul, J., Vogelzang, N.J., Zonnenberg, B.A., Daliani, D.D., Schulman, C.C., Nabulsi, A.A., Humerickhouse, R.A., Weinberg, M.A., Schmitt, J.L. and Nelson, J.B. (2003) "Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized phase II, placebo-controlled trial", J. Clin. Oncol. 21, 679-689.
4. Dall'Era, M.A., Shih, S.J., Yang, J., Benik, S., Gandour-Edwards, R. and Evans, C.P. (2001) "Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer", Prostate Cancer Prostatic Dis. 4, 106-111.
5. Drexler, H. and Hornig, B. (1999) "Endothelial dysfunction in human disease", J. Mol. Cell. Cardiol. 31, 51-60.
6. Ferrer F.A., Miller, L.J., Andrawis, R.I., Kurtzman, S.H., Albertsen, P.C., Laudone, V.P. and Kreutzer, D.L. (1997) "Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells", J. Urol. 157, 2329-2333.
7. Folkman, J. (1998) Editorial "Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence", Endocrinology 139, 441-442.
8. Franck-Lissbrandt, I., Häggström, S., Damber, J.E. and Bergh, A. (1998) "Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats", Endocrinology 139, 451-456.
9. Furchgott, R.F. and Vanhoutte, P.M. (1989) "Endothelium-derived relaxing and contracting factors", FASEB J. 3, 2007-2018.
10. Gerritsen, M.E. (1987) "Functional heterogeneity of vascular endothelial cells", Biochem. Pharmacol. 36, 2701-2711.
11. Granchi, S., Brocchi, S., Bonaccorsi, L., Baldi, E., Vinci, M.C., Forti, G., Serio, M. and Maggi, M. (2001) "Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens", Prostate 49, 267-277.
12. B ET receptors by the prostatic epithelium and stroma", J. Clin. Endocrinol. Meta. 82, 508-513.
13. Hahn, D., Simak, R., Steiner, G.E., Handisurya, A., Susani, M. and Marberger, M. (2000) "Expresssion of the VEGF-receptor flt-1 in benign, premalignant and malignant prostate tissues", J. Urol. 164, 506-510.
14. Häggström, S., Bergh, A. and Damber, J.E. (2000) "Vascular endothelial growth factor content in metastasizing and nonmetastasizing dunning prostatic adenocarcinoma", Prostate 45 42-50.
15. Hrouda, D., Nicol, D.L. and Gardiner, R.A. (2003) "The role of angiogenesis in prostate development and the pathogenesis of prostate cancer", Urol. Res. 30, 347-355.
16. Joseph, I.B. and Isaacs, J.T. (1998) "Macrophage role in the anti-prostate cancer response to one class of angiogenic agents", J. Natl Cancer Inst. 90, 1648-1653.
17. Kopetz, E.S., Nelson, J.B. and Carducci, M.A. (2002) "Endothelin-1 as a target for therapeutic intervention in prostate cancer", Invest. New Drugs 20, 173-182.
18. Krupski, T., Harding, M.A., Herce, M.E., Golding, K.M., Stoler, M.H. and Theodorescu, D. (2001) "The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells", Growth Factors 18, 287-302.
19. Latil, A., Bieche, I., Pesche, S., Valeri, A., Fournier, G., Cussenot, O. and Lidereau, R. (2000) "VEGF overexpression in clinically localized prostate tumors and neuropillin-1 overexpression in metastatic forms", Int. J. Cancer 89, 167-171.
20. Lees, D.M., Pallikaros, Z. and Corder, R. (2000) "The p55 tumor necrosis factor receptor (CD120a) induces endothelin synthesis in endothelial and epithelial cells", Eur. J. Pharmacol. 390, 89-94.
21. Lissbrant, I.F., Lissbrant, E., Damber, J.E. and Bergh, A. (2001) "Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer", Scand. J. Urol. Nephrol. 35, 437-452.
22. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) "Protein measurement with the folin phenol reagent", J. Biol. Chem. 193, 265-275.
23. Mombouli, J.V. and Vanhoutte, P.M. (1999) "Endothelial dysfunction: from physiology to therapy", J. Mol. Cell. Cardiol. 31, 61-74.
24. van Moorselaar, R.J., van Stratum, P., Borm, G., Debruyne, F.M. and Schalken, J.A. (1991) "Differential antiproliferative activities of alpha- and gamma-interferon and tumor necrosis factor alone or in combinations against two prostate cancer xenografts transplanted in nude mice", Prostate 18, 331-344.
25. Nakajima, Y., DelliPizzi, A., Mallouh, C. and Ferreri, N.R. (1995) "Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines", Urol. Res. 23 205-210.
26. Nelson, J.B., Chan-Tack, K., Hedican, S.P., Magnuson, S.R., Opgenorth, T.J., Bova, G.S. and Simons, J.W. (1996) "Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer", Cancer Res. 56, 663-668.
27. Nelson, J., Bagnato, A., Battistini, B. and Nisen, P. (2003a) "The endothelin axis: emerging role in cancer", Nat. Rev. Cancer 3, 110-116.
28. Nelson, J.B., Nabulsi, A.A., Vogelzang, N.J., Breul, J., Zonnenberg, B.A., Daliani, D.D., Schulman, C.C. and Carducci, M.A. (2003b) "Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan", J. Urol. 169, 1143-1149.
29. Pirtskhalaishvili, G. and Nelson, J.B. (2000) "Endothelium-derived factors as paracrine mediators of prostate cancer progression", Prostate 44, 77-87.
30. Saita, Y., Yazawa, H., Koizumi, T., Morita, T., Tamura, T., Takenaka, T. and Honda, K. (1998) "Mitogenic activity of endothelin on human cultured prostatic smooth muscle cells", Eur. J. Pharmacol. 349, 123-128.
31. Sordello, S., Bertrand, N. and Plouet, J. (1998) "Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens", Biochem. Biophys. Res. Commun. 251, 287-290.
32. 2+ concentration in endothelial cells", Cell. Physiol. Biochem. 8, 175-184.
33. Stachon, A., Schlüter, T., Köller, M., Weisser, H. and Krieg, M. (2001) "Primary culture of microvascular endothelial cells from human benign prostatic hyperplasia", Prostate 48, 156-164.
34. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. and Sorg, C. (1994) "Macrophages and angiogenesis", J. Leukoc. Biol. 55, 410-422.
35. Thorin, E., Shatos, M.A., Shreeve, S.M., Walters, C.L. and Bevan, J.A. (1997) "Human vascular endothelium heterogeneity. A comparative study of cerebral and peripheral cultured vascular endothelial cells", Stroke 28, 375-381.
36. Walden, P.D., Ittman, M., Monaco, M.E. and Lepor, H. (1998) "Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia", Prostate 34, 241-250.
37. Walsh, K., Sriprasad, S., Hopster, D., Codd, J. and Mulvin, D. (2002) "Distribution of vascular endothelial growth factor (VEGF in prostate disease", Prostate Cancer Prostatic Dis. 5, 119-122.
38. Wang, Y.Z. and Wong, Y.C. (1998) "Sex hormone-induced prostatic carcinogenesis in the noble rat: the rob of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer", Prostate 35, 165-177.
39. Wu-Wong, J.R., Chiou, W.J., Dickinson, R. and Opgenorth, T.J. (1997a) "Endothelin attenuates apoptosis in human smooth muscle cells", Biochem. J. 328, 733-737.
40. Wu-Wong, J.R., Chiou, W.J., Saeed, B., Magnuson, S.R., Dayton, B.D., Ng, S.C. and Opgenorth, T.J. (1997b) "Endothelin receptor in benign prostatic hyperplastic cells. Binding and functional studies", Recept. Signal. Transduct. 7, 165-175.
41. Zhao, X., van Steenbrugge, G.J. and Schroder, F.H. (1992) "Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor", Urol. Res. 20, 193-197.